• FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Sleep Disturbances in Dementia"

    (session captured at the GAPNA 2019 Annual Conference)


    For September/October 2020 - Get Your Free CNE Now!

  • Clinical Care OptionsNew for GAPNA members: Clinical Care Options

    GAPNA has partnered with a Clinical Care Options to offer an ongoing series of free CNE programs available to GAPNA members. "Vaccinations and Healthy Aging: Protecting Your Older Patients From Shingles" is the latest program offered.

    In this live webinar on September 30, 2020  at 3:00 PM, US Eastern, expert faculty expert faculty discuss how important it is to prevent shingles in older patients.

    Find out about it!

  • CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources

     

Lonhala Magnair

Studies Link Adverse Drug Interactions to Elevated Risk for Hospitalization Among the Elderly

A review of 17 studies that assessed specific drug interactions in elderly patients found that 16 of the studies reported an elevated risk for hospitalization in older adults associated with drug interactions.

These interactions included angiotensin-converting enzyme (ACE) inhibitors and potassium-sparing diuretics; ACE inhibitors or angiotensin receptor blockers and sulfamethoxazole/trimethoprim (SMX/TMP); benzodiapines or zolpidem and other medications; calcium channel blockers and macrolide antibiotics; digoxin and macrolide antibiotics; lithium and loop diuretics or ACE inhibitors; phenytoin and SMX/TMP; sulfonylureas and antimicrobial agents; theophylline and ciprofloxacin; and warfarin and antimicrobial agents or non-steroidal anti-inflammatory drugs.

The researchers concluded that when the elderly receive drug therapy, it should be absolutely necessary for the achievement of well-defined goals. They also recommend that an evidence-based, high-priority list of drug interactions in the elderly be developed and maintained.

For more info, see Hines, L.E. et al. (2011). Potentially harmful drug-drug interactions in the elderly: A review. American Journal of Geriatric Pharmacotherapy, 9, 364-377.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: